Salute e Benessere
Mölnlycke® establishes first wound care manufacturing site in China
The manufacturing site, spanning 10,000 m , will be set up in accordance with Mölnlycke's global standards and is expected to initiate production of Mölnlycke wound care products at the end of 2026/early 2027. This strategic move will help future-proof Mölnlycke's growth in China , laying the foundation for future capacity expansion and local job creation.
"This investment brings us closer to our customers in China and reinforces our mission to free patients and caregivers from the burden of wounds, with locally produced, high-quality solutions," adds Jakob Sonnenberg , VP Greater China & India Wound Care at Mölnlycke.
The Changshu site strengthens Mölnlycke's position in Asia and aligns with China's growing demand for advanced, locally manufactured healthcare solutions.
Jamie Smith
Media Relations Manager
Email: jamie.smith@molnlycke.com
Phone: +46 (0)722-553573
Mölnlycke Health Care is a world-leading MedTech company that specialises in innovative solutions for wound care and surgical procedures. Mölnlycke products and solutions are used daily by hospitals, health care providers and patients in over 100 countries around the world. Founded in 1849, Mölnlycke is owned by Investor AB and headquartered in Sweden. www.molnlycke.com
Photo - https://mma.prnewswire.com/media/2813358/Molnlycke_Health_Care.jpg
Logo - https://mma.prnewswire.com/media/2812160/Molnlycke_Logo.jpg
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/molnlycke-establishes-first-wound-care-manufacturing-site-in-china-302604483.html